510(k) Report

510(k) · Cleared

Cleared

Hudson RCI® AddiPak® Unit Dose Vial

K231058510(k) TraditionalCleared Jan 4, 2024266-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medline Industries, LP · CAF Nebulizer (Direct Patient Interface)

Cleared on Jan 4, 2024 as substantially equivalent to K142153 (Teleflexmedical, Inc., 2015) after a 266-day review. Its family tree reaches back 4 generations to 1987. 1 of the 8 devices in its family, counting itself, has a Class I recall.

Decided
Jan 4, 2024
Review
266 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K870332 (1987). 7 ancestors in all, the oldest K840943 (1984). No later device cites it as a predicate yet. 1 of the 8 devices in this family, counting this one, has a Class I recall.

  1. Root · 4 generations backK870332 Prefilled Respiratory Therapy VialsAutomatic Liquid Packaging, Inc. · 1987
  2. 3 generations backK972466 Sodium Chloride Inhalation Solution, UspHolopack International, LP · 1997
  3. 2 generations backK113033 Sodium Chlorde Inhalation Solution, 0.9% Usp-3MLNephron Pharmaceuticals Corp. · 2012
  4. 1 generation backK142153 Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution…Teleflexmedical, Inc. · 2015 · Recalled (Class I)
  5. This deviceK231058 Hudson RCI® AddiPak® Unit Dose VialMedline Industries, LP · 2024

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K870332Prefilled Respiratory Therapy VialsAutomatic Liquid Packaging, Inc.1987—
−3K972466Sodium Chloride Inhalation Solution, UspHolopack International, LP1997—
−2K113033Sodium Chlorde Inhalation Solution, 0.9% Usp-3MLNephron Pharmaceuticals Corp.2012—
−1K142153Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution…Teleflexmedical, Inc.2015Class I
0 (this device)K231058Hudson RCI® AddiPak® Unit Dose VialMedline Industries, LP2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198410
198810
199810
FIG. 1 — Lineage of K231058, 1987–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142153Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution, 3ML;5ML;15ML
Summary page 5
…F Classification Panel: Anesthesiology (Respiratory) Regulatory Class: Class II Regulation Number: 21 CFR 868.5630 Predicate Device Hudson RCI® AddiPak® Unit Dose Vials K142153 Reference Devices Holopack K972466 – Sodium Chloride Inhalation Solution K972467 – Sterile Water for Inhalation Device Descript…
Teleflexmedical, Inc.2015Class I
†K972466Sodium Chloride Inhalation Solution, UspHolopack International, LP1997—
†K972467Sterile Water for Inhalation, UspHolopack International, LP1997—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K142153Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution, 3ML;5ML;15MLTeleflexmedical, Inc. · 2015 · Direct predicate · ◆ on the line of descent in FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 37 years and passes through 5 companies; a new generation was cleared every 10.4 years on median.
  • 1 of the 7 ancestors has a recall of any class; 1 has a Class I recall.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The AddiPak® Unit Dose Vial may be used in conjunction with a non-ventilator nebulizer for lavage therapy, or for tracheal irrigation.

These products are single-use, disposable, and intended for inhalation only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231058: Hudson RCI® AddiPak® Unit Dose Vial.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231058

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026